Phoenix Nest Inc.
NY
- UEI
- C43HHASBLCV6
- CAGE
- 6PP02
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 710 6th Ave #2a, Brooklyn, NY 11215, USA
- Website
- phoenixnestbiotech.com
- Founded
- 2012
- Employees
- 11-50
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Biotechnology
- SIC code
- 28 Chemical & Allied Products
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
About Phoenix Nest Inc.
Phoenix Nest Inc. is a woman-owned small business focused on developing innovative therapeutic solutions for rare genetic disorders, particularly lysosomal storage diseases. Registered in SAM.gov since 2012, the company specializes in gene therapy research and development, with a primary emphasis on neurological disorders that currently lack effective treatments. The organization operates as a for-profit corporate entity that collaborates with academic institutions and clinical research providers to advance experimental therapies for rare genetic conditions.
Phoenix Nest Inc. has secured multiple federal grants from the National Institute of Neurological Disorders and Stroke (NINDS) to support advanced research in gene replacement therapies for Mucopolysaccharidosis (MPS) disorders, specifically focusing on Sanfilippo Syndrome Types C and D. The company's federal grant awards, totaling nearly $881,675, support critical research activities including developing gene therapy approaches for MPS IIIC using AAV9 gene therapy, conducting natural history studies, establishing clinical outcome assessments, and preparing for interventional clinical trials. Key research partners include the University of Texas Southwestern Medical Center and NYU, with the company working to develop therapeutic strategies for rare pediatric neurological disorders that currently have no available treatments. Their research aims to create potential long-term therapeutic interventions for devastating genetic conditions that cause progressive neurological deterioration, with a particular focus on developing clinical tools, biomarkers, and innovative gene replacement technologies.
Quick answers
What is Phoenix Nest Inc.'s UEI?
Phoenix Nest Inc.'s Unique Entity ID (UEI) in SAM.gov is C43HHASBLCV6.
What is Phoenix Nest Inc.'s CAGE code?
Phoenix Nest Inc.'s CAGE code is 6PP02.
What is Phoenix Nest Inc.'s primary NAICS code?
Phoenix Nest Inc.'s primary NAICS code is 541714 (Research and Development in Biotechnology (except Nanobiotechnology)).
Where is Phoenix Nest Inc. located?
Phoenix Nest Inc.'s physical address in SAM.gov is 710 6th Ave #2a, Brooklyn, NY 11215, USA.
Is Phoenix Nest Inc. registered in SAM.gov?
Yes. Phoenix Nest Inc.'s SAM.gov registration is active through August 5, 2027.
What is Phoenix Nest Inc.'s most recent federal award?
Phoenix Nest Inc.'s most recent federal grant award is Manufacturing and analytical development for JLK-247 gene therapy - project summary/abstract lysosomal storage… (R44NS147802), from National Institute of Neurological Disorders and Stroke, on July 14, 2026.
On GovTribe
See Phoenix Nest Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors